Effects of semaglutide vs bariatric surgery on noninvasive markers of hepatic steatosis and fibrosis in obesity with metabolic dysfunction-associated steatotic liver disease

Paula Lünswilken, Katarzyna Worobiec, Lara S Braun, Julia Altrogge, Andrea Schenk, Lina Jegodzinski, Britta Wilms, Jens U Marquardt, Svenja Meyhöfer

Open source

DOI: 10.1210/clinem/dgag350
Published: 2026-08-27
Container: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1210/clinem/dgag350,
  title = {Effects of semaglutide vs bariatric surgery on noninvasive markers of hepatic steatosis and fibrosis in obesity with metabolic dysfunction-associated steatotic liver disease},
  author = {Paula Lünswilken and Katarzyna Worobiec and Lara S Braun and Julia Altrogge and Andrea Schenk and Lina Jegodzinski and Britta Wilms and Jens U Marquardt and Svenja Meyhöfer},
  year = {2026},
  journal = {The Journal of Clinical Endocrinology \&amp; Metabolism},
  doi = {10.1210/clinem/dgag350},
  url = {https://doi.org/10.1210/clinem/dgag350}
}

RIS

TY  - JOUR
TI  - Effects of semaglutide vs bariatric surgery on noninvasive markers of hepatic steatosis and fibrosis in obesity with metabolic dysfunction-associated steatotic liver disease
AU  - Paula Lünswilken
AU  - Katarzyna Worobiec
AU  - Lara S Braun
AU  - Julia Altrogge
AU  - Andrea Schenk
AU  - Lina Jegodzinski
AU  - Britta Wilms
AU  - Jens U Marquardt
AU  - Svenja Meyhöfer
PY  - 2026
JO  - The Journal of Clinical Endocrinology &amp; Metabolism
DO  - 10.1210/clinem/dgag350
UR  - https://doi.org/10.1210/clinem/dgag350
ER  -

APA

Lünswilken, P., Worobiec, K., Braun, L. S., Altrogge, J., Schenk, A., Jegodzinski, L., Wilms, B., Marquardt, J. U., & Meyhöfer, S. (2026). Effects of semaglutide vs bariatric surgery on noninvasive markers of hepatic steatosis and fibrosis in obesity with metabolic dysfunction-associated steatotic liver disease. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag350

Source records

crossref · retrieved 2026-09-25T19:54:19.371Z